NCT00521885View on ClinicalTrials.gov

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Venous Thrombosis
Interventions
DRUG

Arixtra (Fondaparinox) 2.5 mg SC Daily

Patients will be randomized to receive Arixtra 2.5mg once a day if randomized to this arm

DRUG

Lovenox 40mg SC Daily

Patients will be randomized to receive Lovenox 40mg SC Daily if randomized to this arm

Trial Locations (1)

18017

Lehigh Valley Hospital Muhlenberg, Bethlehem

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Lehigh Valley Hospital

OTHER